logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
7-day trial • $39/mo or $29/mo annual
AI + proprietary hiring database
Executive contact details included
INDUSTRY FIRST

C Trl Therapeutics Appoints Derrell D. Porter, M.D., As Chief Executive Officer

Nov 01, 2023over 1 year ago

Position

Chief Executive Officer

Company

CTRL Therapeutics

Derrell D. Porter
GlencoeBiotechnology

Description

cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes in the blood to broaden the power and reach of solid tumor cell therapy to more patients, today announced the appointment of Derrell D. Porter, M.D., as Chief Executive Officer.

Company Information

Company

CTRL Therapeutics

Location

Glencoe, Illinois, United States

About

cTRL Therapeutics is building a new company to transform the cell therapy space by developing autologous cell therapies for patients with solid tumors. We are building a company culture based on collaboration, transparency, integrity, and commitment to excellence. We are looking for passionate people to be a part of this journey.

FundzWatch™ Score

22
Medium Activity
3 total signals

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months